Patents by Inventor John R. Regan

John R. Regan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4746676
    Abstract: Compounds having the general structure ##STR1## and their pharmaceutically acceptable salts, wherein the substituents are defined herein, which exhibit antihypertensive activity.
    Type: Grant
    Filed: September 12, 1984
    Date of Patent: May 24, 1988
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Edward S. Neiss, John T. Suh, John R. Regan, Jerry W. Skiles, Jeffrey N. Barton, Paul Menard
  • Patent number: 4666906
    Abstract: Compounds of the formula ##STR1## and their pharmaceutically acceptable salts, wherein the substituents are as defined herein, having antihypertensive activity.
    Type: Grant
    Filed: July 19, 1985
    Date of Patent: May 19, 1987
    Assignee: USV Pharmaceutical Corporation
    Inventors: John J. Piwinski, John T. Suh, Paul Menard, Howard Jones, Edward S. Neiss, John R. Regan
  • Patent number: 4555508
    Abstract: Compounds having the general structure ##STR1## and their pharmaceutically acceptable salts, wherein the substituents are defined herein, which exhibit antihypertensive activity.
    Type: Grant
    Filed: March 2, 1984
    Date of Patent: November 26, 1985
    Assignee: USV Pharmaceutical Corp.
    Inventors: John T. Suh, John R. Regan, John J. Piwinski, Paul Menard, Howard Jones
  • Patent number: 4500713
    Abstract: (3S)-2-N-[(1S)-1-Ethoxycarbonyl-1-(2,3-dihydro-1H-inden-2-yl)-methyl]-L-ala nyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid is a antihypertensive agent.
    Type: Grant
    Filed: September 23, 1982
    Date of Patent: February 19, 1985
    Assignee: USV Pharmaceutical Corporation
    Inventors: John T. Suh, Jeffrey N. Barton, John R. Regan